Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.070 |
None |
1.000 |
7 |
|
1989 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.070 |
None |
1.000 |
7 |
|
1995 |
2020 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.060 |
None |
1.000 |
6 |
|
1989 |
2019 |
Alzheimer's Disease
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
3397
|
1843
|
0.350 |
None |
1.000 |
6 |
2
|
2002 |
2012 |
Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
3097
|
353
|
0.050 |
None |
1.000 |
5 |
|
2017 |
2019 |
Brain Neoplasms
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
1018
|
204
|
0.040 |
None |
0.750 |
4 |
|
1995 |
2018 |
HEMOCHROMATOSIS, TYPE 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
83
|
62
|
0.130 |
None |
1.000 |
4 |
2
|
2005 |
2015 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.340 |
None |
0.333 |
4 |
2
|
2007 |
2012 |
Alzheimer Disease, Late Onset
|
disease |
Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
385
|
243
|
0.310 |
None |
1.000 |
3 |
|
2003 |
2007 |
Total iron binding capacity function
|
phenotype |
|
Clinical Attribute
|
20
|
35
|
0.100 |
None |
1.000 |
3 |
5
|
2011 |
2017 |
Glioblastoma Multiforme
|
disease |
Neoplasms
|
Neoplastic Process
|
3197
|
186
|
0.030 |
None |
1.000 |
3 |
|
2014 |
2018 |
Finding of Mean Corpuscular Hemoglobin
|
phenotype |
|
Finding
|
653
|
1206
|
0.100 |
None |
1.000 |
3 |
5
|
2016 |
2019 |
Iron binding capacity total measurement
|
phenotype |
|
Laboratory Procedure
|
20
|
35
|
0.100 |
None |
1.000 |
3 |
5
|
2011 |
2017 |
Hemochromatosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
93
|
45
|
0.030 |
None |
1.000 |
3 |
1
|
2005 |
2012 |
Alcohol abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
156
|
24
|
0.310 |
None |
1.000 |
3 |
|
2000 |
2011 |
Transferrin measurement
|
phenotype |
|
Laboratory Procedure
|
6
|
10
|
0.100 |
None |
1.000 |
3 |
3
|
2011 |
2015 |
Serum transferrin measurement
|
phenotype |
|
Laboratory Procedure
|
6
|
10
|
0.100 |
None |
1.000 |
3 |
3
|
2011 |
2015 |
Age related macular degeneration
|
disease |
Eye Diseases
|
Disease or Syndrome
|
685
|
663
|
0.030 |
None |
1.000 |
3 |
4
|
2006 |
2013 |
Hereditary hemochromatosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
254
|
56
|
0.120 |
None |
1.000 |
3 |
1
|
1984 |
2015 |
leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
2111
|
144
|
0.020 |
None |
1.000 |
2 |
|
1985 |
1992 |
Mammary Carcinoma, Animal
|
disease |
Neoplasms; Animal Diseases
|
Neoplastic Process
|
144
|
|
0.300 |
None |
1.000 |
2 |
|
1998 |
2005 |
Anaplastic carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
232
|
3
|
0.300 |
None |
1.000 |
2 |
|
1998 |
2005 |
Transferrin saturation measurement
|
phenotype |
|
Laboratory Procedure
|
26
|
36
|
0.100 |
None |
1.000 |
2 |
3
|
2014 |
2017 |
Undifferentiated carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
283
|
8
|
0.300 |
None |
1.000 |
2 |
|
1998 |
2005 |
RDW - Red blood cell distribution width result
|
phenotype |
|
Laboratory or Test Result
|
593
|
988
|
0.100 |
None |
1.000 |
2 |
2
|
2016 |
2019 |